SNST (Aphex BioCleanse Systems) Stock Based Compensation: $0.00 Mil (TTM As of . 20)


What is Aphex BioCleanse Systems Stock Based Compensation?

Aphex BioCleanse Systems SNST Stock Based Compensation is $0.00 Mil as of . 20.

Aphex BioCleanse Systems's Stock Based Compensation for the three months ended in . 20 was $0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

Aphex BioCleanse Systems Stock Based Compensation Related Terms

Aphex BioCleanse Systems Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Aphex BioCleanse Systems's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aphex BioCleanse Systems Stock Based Compensation Chart

Aphex BioCleanse Systems Annual Data
Trend
Stock Based Compensation

Aphex BioCleanse Systems Quarterly Data
Stock Based Compensation

Aphex BioCleanse Systems Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

What does a Stock Based Compensation of $0.00 Mil mean?
Aphex BioCleanse Systems (SNST) has a Stock Based Compensation of $0.00 Mil as of . 20. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Aphex BioCleanse Systems and its competitors.
Is Aphex BioCleanse Systems' Stock Based Compensation too high?
Aphex BioCleanse Systems' current Stock Based Compensation is $0.00 Mil.
How does Aphex BioCleanse Systems' Stock Based Compensation compare to competitors?
Aphex BioCleanse Systems' Stock Based Compensation of $0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Consumer Packaged Goods company?
A good Stock Based Compensation depends on the Consumer Packaged Goods industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Aphex BioCleanse Systems and its competitors. Aphex BioCleanse Systems's current Stock Based Compensation is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aphex BioCleanse Systems stock overvalued right now?
Aphex BioCleanse Systems (SNST) has a current Stock Based Compensation of $0.00 Mil. The current Stock Based Compensation is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Aphex BioCleanse Systems (SNST), the current Stock Based Compensation is $0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aphex BioCleanse Systems Business Description

Address 1820 State Road 13, Unit 11-43, Saint Johns, FL, USA, 32259
Aphex BioCleanse Systems Inc is a United States-based company that provides sanitization solutions. It develops and manufactures non-alcohol, non-toxic, and hydrogen-based disinfecting technology. The company produces proprietary hydrogen-based disinfectant and pesticide products known as Hy-IQ Water.